Related FOLDMid-Morning Market Update: Markets Gain; Finish Line Beats Q1 ViewsMorning Market GainersRelated IPXLUS Stock Futures Signal Higher Start On Wall StreetImpax Announces Sale of Daraprim to Turing Pharmaceuticals AG , ~$55MAquinox’s Shares Shoot Up, Bladder Pain Drug in Focus(Zacks)In a recent report, analysts at Leerink shared their views on a ton of biotech stocks. Here is a look at […]
Related LFStocks Hitting 52-Week LowsMorning Market LosersEven A Kiss From A Princess Can’t Save LeapFrog(Seeking Alpha)In a report published Monday, BMO Capital Markets analyst Gerrick L. Johnson maintained an Outperform rating on LeapFrog Enterprises, Inc. (NYSE: LF), while reducing the price target from $8 to $4, saying that the company is “leaping backwards.”LeapFrog accounted its F4Q EPS at a loss […]
In a recent report, analysts at JMP Securities discussed five biotech names that are on their radar. Here’s a breakdown of what they had to say.
BIND Therapeutics Inc (NASDAQ: BIND)
BIND will be presenting three posters on its Accurin technology at the American Association of Cancer Research (AACR) meeting in Philadelphia in April.Although the Accurin data the company will be showcasing […]
Social media continues to grow, and part of the big increase is due to mobile apps for the top social media websites. However, one thing is starting to show up in the monthly social media metrics numbers. There is a dominant winner in the space, and others are doing everything they can to stay up to speed.In a new research […]
Stocks hit an all-time high this past week. What is puzzling now is that investors and traders keep hearing that the raging bull market is over, and that this has turned into a stock picker’s market. Investors still will try to make gains, but they will want to avoid getting caught in bad stocks. As 24/7 Wall St. reviews dozens […]
Stocks are still challenging all-time highs, and investors keep hearing that the bull market has now become a stock picker’s market. What this means is that investors still will try to make gains, but they will want to avoid getting caught in bad stocks. As 24/7 Wall St. reviews dozens of analyst upgrades and downgrades each week, it turns out […]
Cosmetics company Estée Lauder (NYSE:EL) made for some mighty impressive trading collars on Friday. Shares surged 4.75% to end at an historic high – no mean feat in a week when its arch-rival Avon Products (NYSE:AVP) imploded. The firm, whose myriad other brands include Aramis, Aveda, Bobbi Brown, Bumble and bumble, Clinique, Flirt!, Origins, and Smashbox, boosted its profit outlook. Today, however, its excessive subsequent […]
Someone in America may be about to get mighty rich today, but if a week from hell that appropriately ends on Friday the 13th is any indication, it won’t be on Wall Street. US stock markets slumped again, with the S&P 500 Index (INDEXSP:.INX) now down 1.5% in December, a historically stellar month. As for the bearded Three Wise Men […]
